What You Should Know:– Atropos Health, a pioneer in real-world evidence (RWE) generation, announced a collaboration with Merck to leverage its innovative platform for rapid insights and analytics from real-world data (RWD).– The strategic partnership will enable Merck’s data science and RWE teams to conduct advanced analyses and generate publication-grade studies in less than 48 hours.– The collaboration follows Atropos Health’s recent launch of ChatRWD™, a groundbreaking generative AI application for rapid RWE generation. In May 2024, the company also secured $33M in funding to advance its AI-driven approach to health data analysis.Accelerating RWE for Life Savings TreatmentsMerck will utilize a suite of Atropos Health’s services, including:GENEVA OS™: A generative evidence acceleration operating system that facilitates rapid cohort creation and advanced analytics.A generative evidence acceleration operating system that facilitates rapid cohort creation and advanced analytics. Green Button™: A tool that simplifies the process of asking clinical questions and generating RWE.A tool that simplifies the process of asking clinical questions and generating RWE. Atropos Evidence™ Network: Access to the industry’s largest federated healthcare data network, with over 300 million patient records.Access to the industry’s largest federated healthcare data network, with over 300 million patient records. Alexandria™: A repository of existing studies that can be rerun on local data to generate novel insights.A repository of existing studies that can be rerun on local data to generate novel insights. Forge™: A low-code research platform for rapid cohort creation and advanced patient studies.A low-code research platform for rapid cohort creation and advanced patient studies

TEL AVIV, Israel-(BUSINESS WIRE)-QuantHealth, an AI-powered drug development platform, announced today its partnership with Atropos Health, a leader in translating clinical data into high-quality, personalized, real-world evidence for care.

What You Should Know:– Atropos Health, a leader in translating clinical data into high-quality, personalized, real-world evidence (RWE) for care, today announced the availability of AI model training on the Atropos Evidence Network, the largest federated healthcare data network with more than 300 million patient records.– Atropos Evidence Network members can utilize certain de-identified real-world data (RWD) to train AI models and seamlessly deploy their technology via channel partner systems, including pharmaceutical companies and health systems like Stanford.Transforming Healthcare Through Real-World Data and Responsible AI: Atropos Health’s GENEVA OS™Atropos Health, the developer of GENEVA OS™, revolutionizes healthcare with an innovative operating system for rapid evidence generation from a robust real-world data (RWD) network. Collaborating with healthcare and life science organizations, Atropos Health bridges evidence gaps from research to patient care, enhancing individual outcomes through data-driven care and accelerating advancements in medicine.Advancing AI Model Training Across the Healthcare EcosystemAtropos Health facilitates AI model training, benefiting key stakeholders within the healthcare ecosystem:AI Developers : Test tools and applications, including artificial intelligence (AI), machine learning (ML), large language models (LLM), and natural language processing (NLP), using high-quality RWD from the Atropos Evidence Network.: Test tools and applications, including artificial intelligence (AI), machine learning (ML), large language models (LLM), and natural language processing (NLP), using high-quality RWD from the Atropos Evidence Network. Health Systems : Evaluate in-house AI models on the largest federated healthcare data network while adhering to standards for AI transparency and bias detection. Institutions can also partner with advanced models developed by others.: Evaluate in-house AI models on the largest federated healthcare data network while adhering to standards for AI transparency and bias detection. Institutions can also partner with advanced models developed by others. Life Sciences Organizations : Build, test, train, and distribute AI models to uncover overlooked patient populations, leveraging Atropos Health’s provider network for real-world applications.: Build, test, train, and distribute AI models to uncover overlooked patient populations, leveraging Atropos Health’s provider network for real-world applications